Mostafa Ronaghi is an Iranian molecular biologist, specializing in deoxyribonucleic acid sequencing methodology.
He earned his Doctor of Philosophy from the Royal Institute of Technology in Sweden in 1998.
As of 2008, he is the Chief Technology Officer and Senior Vice President at Illumina. Prior to this position, he was a principal investigator and Senior Research Associate at the Stanford Genome Technology Center at Stanford University, focusing on developing analytical techniques for molecular diagnostics. He is principal investigator for several grants including grants from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health for the development of array-based Pyrosequencing.
He is a co-inventor (with Pål Nyrén) of pyrosequencing technology and co-founded Pyrosequencing Bachelor of Arts in 1997 (renamed to Biotage in 2003), and co-invented Molecular Inversion Probe assay and co-founded ParAllele BioScience to develop this multiplexed technology for genetic testing.
ParAllele was acquired by Affymetrix in May 2005. In 2005, he co-founded NextBio, a search engine for life science data that was acquired by Illumina in 2013.
He also serves on the board of directors of IntegenX and Aurora Biofuels. In 2008 he co-founded Avantome, a deoxyribonucleic acid sequencing company acquired by Illumina July 2008.